Loading…
← CockpitCompetitor Analysis › RHC.AX Ramsay Health Care LimitedOpen in the cockpit ↗

Ramsay Health Care LimitedRHC.AXCompetitor analysis, valuation and peers

Australia · AUD·Health Care›Hospital/Nursing Management

Global private-hospital operator with major networks in Australia, the UK and France, providing acute and surgical care.

≈ Australia's HCA HealthcareMomentum leader 93
Mkt cap
$8.31B
US dollars, full cap
Free float
76%
of shares outstanding
$/day
$23.2M
20-day average traded
Fwd P/E
31.4×
forward earnings
ROIC−WACC
-3.0 pp
WACC 7.3%
Hurdle
+6 pp
Req g minus delivered
Next earnings
105 days
3 Mar 2027
Close · AUDA$53.58
1D-0.1%
1W-4.4%
1M-1.0%
3M+19.1%
6M+41.3%
YTD+55.9%
1Y+68.5%
ATR %1.8%
52w lowhigh5.2% off high

What Ramsay Health Care does

Global private-hospital operator with major networks in Australia, the UK and France, providing acute and surgical care.

Hospitals are paid per patient episode by private health insurers and, in the UK and France, by government health systems that contract out surgery and care, so volumes depend on insurer funding and waiting lists. Europe runs through its subsidiary Ramsay Sante, which is itself listed in Paris, and carries a large share of activity alongside Australia.

In one line: Australia's HCA Healthcare.

Products and services

  • Australian private hospitals
  • UK hospitals
  • French hospitals (Ramsay Santé)
  • Psychiatric/mental health care

Customers

  • Privately insured patients
  • Health insurers
  • Government health systems (contracted services)

Where it sits in the supply chain

  • Healthcare services
  • Private hospital operation
  • Acute care, surgery, mental health

What could go right

  • Ageing population surgical demand
  • Private health insurance growth

What could go wrong

  • Health insurer/government funding pressure
  • Rising labour/staffing costs

Moat: narrow (scale, installed base, regulatory licence). Large multi-country network of licensed hospitals with doctor relationships that are slow to replicate.

Headquarters: Sydney, Australia · Founded: 1964 · Employees: 92,400

Named competitors

Ramsay Health Care at a glance

Size Ramsay Health Care (RHC.AX) is an Australia Health Care company (Hospital/Nursing Management) with a market value of $8.31B, the 41st largest of 317 Australia companies the cockpit tracks. Shares closed at A$53.58 on 18 Nov 2026.

Performance Over six months the shares gained 41.3%, against +9.9% for the median peer and +1.2% for the Australia market (cap-weighted) — 4th highest of 16 in its peer set.

Growth Revenue grew 4.4% over the last twelve months (peer median +13.1%); the operating margin is 5.5% (peer median 13.4%).

Valuation It trades at 31.4× forward earnings against a peer median of 48.5× (7th cheapest of 16).

Price implies For today's price to make sense, revenue must grow about 14% a year for seven years (Req g). Recent delivered growth is +8%, so the hurdle is +6 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 3.0 points below its cost of capital (7.3% WACC).

Next results Next results expected around 3 Mar 2027 (exchange calendar; dates can move).

Relative performance

10012014021 May 202621 Aug 202618 Nov 2026RHC.AX 143Peer median 109
Six months, rebased to 100: Ramsay Health Care against the median of its 16 peers (local-currency closes).

Ramsay Health Care financials

Reported figures in AUD; fiscal year ends 2026-06-30. TTM = trailing twelve months.
TTMFY2026FY2025FY2024FY2023
RevenueA$18.6BA$18.6BA$17.7BA$16.7BA$15.0B
Revenue growth—+5%+6%+11%—
Gross profitA$1.77BA$1.77BA$1.66BA$1.61BA$1.27B
EBITDAA$2.20BA$2.20BA$2.05BA$2.02BA$1.65B
Net incomeA$329MA$329MA$24.0MA$889MA$298M
Free cash flowA$708MA$708MA$721MA$548MA$579M
Capital expenditureA$734MA$734MA$777MA$754MA$721M
Total debtn/aA$11.0BA$12.1BA$10.9BA$11.9B

Quarterly statements and history in the cockpit →

Ramsay Health Care competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

0%+50%+100%0%+50%PACSCHEASTERDMMAXHEALTHUHSFORTISAPOLLOHOSPNHSGRYTHCNHCFRERHC.AX6-month return →1-month return →
Up and to the right = strong over both horizons. Ramsay Health Care is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%+60%25×50×75×PACSMANIPALHOSCHEASTERDMMAXHEALTHUHSFORTISAPOLLOHOSPNHMEDANTASGRYKIMS600763RHC.AXRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Ramsay Health Care is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%PACSMANIPALHOSCHEASTERDMMAXHEALTHUHSFORTISAPOLLOHOSPNHSGRYTHCNHC600763FRERHC.AXGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Ramsay Health Care is the large dot.

Ramsay Health Care competitors and peer comparison

Head to head with its named competitors (RHC.AX vs HCA vs SPI.L)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Ramsay Health Care RHC.AX$8.31B+41%+4%5%31.4×14.0%
HCA Healthcare HCA$99.5B+20%+6%15%15.6×3.1%
Spire Healthcare SPI.L$1.31B+11%+2%8%25.1×10.0%

How Ramsay Health Care compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Ramsay Health Care against its 16 peers (data as of 18 Nov 2026)
MeasureRHC.AXPeer medianRank in peer set
1-month return-1.0%+9.0%3rd lowest of 17
6-month return+41.3%+9.9%4th highest of 16
Distance from 52-week high-5.2%-11.0%5th highest of 17
Revenue growth (TTM)+4.4%+13.1%2nd lowest of 17
Operating margin5.5%13.4%2nd lowest of 17
Forward P/E31.4×48.5×7th cheapest of 16
Growth the price implies (Req g, 7 yrs)14.0%14.0%8th least demanding of 15
Growth delivered (Del g)+8.3%+10.9%6th lowest of 15
Hurdle (Req g minus delivered)+5.6 pp+4.8 pp7th most demanding of 15
ROIC minus cost of capital-3.0 pp-0.8 pp7th lowest of 17
EV / EBITDA10.7×25.3×3rd cheapest of 15
Net debt / EBITDA4.7×2.2×4th most indebted of 16

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Ramsay Health Care RHC.AXAustralia$8.31B+41%+4%5%31.4×14.0%+8.3%
PACS PACSUnited States$7.35B+25%+11%8%17.5×7.5%+29.7%
Manipal Health Enterprises MANIPALHOS.NSIndia$9.69Bn/a+25%19%66.5×32.9%+28.8%
Chemed CHEUnited States$7.12B+24%+5%14%20.2×3.3%+4.0%
Aster DM Quality Care ASTERDM.NSIndia$6.83B-2%+50%16%63.5×48.6%-11.6%
Max Healthcare Institute MAXHEALTH.NSIndia$10.6B-4%+15%21%55.2×45.3%+27.2%
Universal Health Services UHSUnited States$10.7B+13%+8%11%8.3×-1.8%+8.5%
Fortis Healthcare FORTIS.NSIndia$6.40B-17%+18%17%48.5×42.5%+17.9%
Apollo Hospitals Enterprise APOLLOHOSP.NSIndia$13.6B+10%+19%12%51.0×33.3%+19.0%
Narayana Hrudayalaya NH.NSIndia$4.13B0%+71%13%34.2×31.2%+25.0%
Global Health MEDANTA.NSIndia$4.13B+16%+26%17%50.4×n/an/a
Surgery Partners SGRYUnited States$3.53B+100%+2%13%77.2×15.6%+12.2%
Krishna Institute of Medical Sciences KIMS.NSIndia$3.41B+2%+35%11%81.9×n/an/a
Tenet Healthcare THCUnited States$21.6B+45%+6%17%13.4×-1.4%+3.9%
National HealthCare NHCUnited States$3.16B+1%+6%0%n/a6.4%+9.7%
Topchoice Medical 600763.SSChina$2.33B-12%+7%26%24.8×12.4%+6.9%
Fresenius SE & Co. KGaA FRE.DEGermany$32.7B+41%+7%10%14.7×7.0%-8.8%

Questions

Who are Ramsay Health Care's main competitors?
Named competitors: HCA Healthcare (HCA), Spire Healthcare (SPI.L), Elsan (private or unlisted). The cockpit's measured peer set (industry) also includes PACS (PACS), Manipal Health Enterprises (MANIPALHOS.NS), Chemed (CHE), Aster DM Quality Care (ASTERDM.NS), Max Healthcare Institute (MAXHEALTH.NS), Universal Health Services (UHS).
Is Ramsay Health Care expensive compared with its peers?
On forward p/e it trades at 31.4× against a peer median of 48.5×, 7th cheapest of 16 in its peer set. For today's price to make sense, revenue must grow about 14% a year for seven years (Req g). Recent delivered growth is +8%, so the hurdle is +6 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Ramsay Health Care stock performed?
Over six months to 18 Nov 2026 the shares returned +41.3% against +9.9% for the median peer; over one year +68.5%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.